Sandy Draper's Stock Ratings

Guggenheim Analyst

Sandy Draper is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/25/2024

Overall Average Return

16.6%

Smart Score

71.4%

Overall Average Return Percentile

74th

Number of Ratings

210
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs
Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings
Assessing Medpace Hldgs: Insights From 9 Financial Analysts
Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs
Expert Ratings For Medpace Hldgs
A Glimpse Into The Expert Outlook On Medpace Hldgs Through 6 Analysts
Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Accolade, Inc. (NASDAQ: ACCD) is expected to release financial results for its fiscal second quarter 2024 after the closing bell on Oct. 4, 2023.
Why Doximity Stock Took A Nosedive Today
Doximity, Inc. (NYSE: DOCS) shares fell Wednesday after the company issued second-quarter and full-year 2023 revenue guidance below estimates.
Cathie Wood Trims Tesla Stake Ahead Of Next Week's Stock Split — Loads Up $11M In This Telehealth Stock
Cathie Wood-led Ark Investment Management bought 311,073 Teladoc Health Inc (NYSE: TDOC) shares valued at over $11 million, through four of its exchange-traded funds, according to the firm's trading disclosure.
Why This Teladoc Health Analyst Expects 25%-30% Revenue Growth
Teladoc Health Inc (NYSE: TDOC) is a market leader in digital services, and the breadth of its services is unmatched, according to Guggenheim. The Teladoc Health Analyst: Sandy Draper initiated coverage of Teladoc Health with a Buy rating and $96 price target.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved